BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $539M | $2.0B | $414M | $865M | $928M | $1.9B | $1.7B | $217M | $146M | $188M | $196M | $319M | $587M | $217M | $207M | $267M | $213M | $864M | $1.6B | $1.5B |
| Inventory | $3.2B | $2.9B | $2.8B | $2.5B | $1.9B | $1.6B | $1.4B | $1.6B | $1.2B | $1.1B | $955M | $1.0B | $946M | $897M | $884M | $931M | $894M | $891M | $853M | — |
| Current assets | $8.0B | $8.8B | $6.9B | $6.5B | $5.8B | $6.3B | $6.7B | $4.7B | $4.0B | $3.8B | $3.2B | $3.5B | $3.6B | $3.0B | $3.0B | $3.1B | $3.6B | $4.6B | $5.5B | — |
| Goodwill | $18.6B | $18.3B | $17.1B | $14.4B | $12.9B | $12.0B | $10.0B | $10.2B | $7.9B | $7.0B | $6.7B | $6.5B | $5.9B | $5.7B | $6.0B | $9.8B | $10.2B | $11.9B | $12.4B | — |
| Intangible assets | $6.9B | $7.0B | $6.7B | $6.0B | $5.9B | $6.1B | $5.9B | $7.9B | $6.4B | $5.8B | $5.9B | $6.2B | $5.6B | $6.0B | $6.3B | $6.5B | $6.3B | $6.7B | $7.2B | — |
| Total assets | $45.2B | $43.7B | $39.4B | $35.1B | $32.5B | $32.2B | $30.8B | $30.6B | $21.0B | $19.0B | $18.1B | $18.1B | $17.0B | $16.6B | $17.2B | $21.3B | $22.1B | $25.2B | $27.1B | — |
| Current liabilities | $6.4B | $5.4B | $6.4B | $4.9B | $3.8B | $4.3B | $3.7B | $4.9B | $5.3B | $5.7B | $3.6B | $2.4B | $2.8B | $1.8B | $1.8B | $1.8B | $2.6B | $3.0B | $3.2B | — |
| Long-term debt | $10.9B | $11.1B | $9.0B | $8.6B | $8.9B | $8.8B | $9.1B | $8.6B | $4.8B | $3.8B | $5.4B | $5.7B | $3.8B | $4.2B | $4.2B | $4.2B | $5.5B | $5.9B | $6.7B | — |
| Total liabilities | $20.0B | $19.2B | $17.4B | $15.6B | $14.9B | $15.6B | $15.5B | $16.7B | $12.3B | $12.0B | $11.4B | $11.8B | $10.6B | $10.0B | $10.3B | $9.9B | $10.8B | $12.9B | $14.0B | — |
| Shareholders' equity | $24.9B | $24.2B | $21.8B | $19.3B | $17.6B | $16.6B | $15.3B | $13.9B | $8.7B | $7.0B | $6.7B | $6.3B | $6.5B | $6.5B | $6.9B | $11.4B | $11.3B | $12.3B | $13.2B | — |
| Shares outstanding | 1.45B | 1.48B | 1.48B | 1.47B | 1.43B | 1.43B | 1.42B | 1.40B | 1.39B | 1.37B | 1.36B | 1.35B | 1.33B | 1.32B | 1.36B | 1.45B | 1.52B | 1.51B | — | — |
| Current ratio | 1.24 | 1.62 | 1.08 | 1.32 | 1.51 | 1.48 | 1.82 | 0.97 | 0.76 | 0.68 | 0.90 | 1.43 | 1.27 | 1.65 | 1.71 | 1.72 | 1.39 | 1.52 | 1.69 | — |